Knowledge of cancer diagnosis contributes to longer survival time

NewsGuard 100/100 Score

In a study of adults in China with lung cancer, patients who knew of their cancer diagnosis generally survived longer than those who did not.

In the Psycho-Oncology study of 29,825 patients, the median survival time in patients who knew of their diagnosis was 18.33 months versus 8.77 months for those who did not.

The study's authors noted that the survival benefits of the awareness of cancer diagnoses in patients is a controversial topic in some countries due to their culture and customs. In China, cultural, social, and legal factors play a role in not fully revealing disease status to patients with cancer. Usually, doctors first explain cancer diagnoses to patients' families, who determine whether patients will learn of their exact disease status.

Although the complete disclosure of cancer diagnoses may cause emotional disturbance in patients immediately after being told of their diagnosis, it benefits them in the long term. Communication skills training for doctors and psychological support and education for patients and their families should be given more attention in clinical practice."

Yunxiang Tang, MD, Ph.D., Senior Author, The Second Military Medical University, in China

Source:
Journal reference:

Su, T., et al. (2020) Association between early informed diagnosis and survival time in patients with lung cancer. Psycho-Oncology. doi.org/10.1002/pon.5360.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Combined chemohormonal therapy for locally advanced prostate cancer offers extended control of PSA levels